Newsletter – Spring 2024

Welcome to the third edition of our Newsletter which has been designed to be as informative as possible to everyone affected by GIST Cancer. It contains information about our most […]

Phase 2 Trial – Avelumab Plus Regorafenib

Combination treatment with avelumab and regorafenib has shown activity in patients with relapsed/refractory gastrointestinal stromal tumors (GIST), according to research presented at the European Society for Medical Oncology (ESMO) Congress […]

Newsletter – Autumn 2023

Welcome to the second edition of our Newsletter which has been designed to be as informative as possible to everyone affected by GIST Cancer. It contains information about our most […]

Leeds Sessions 2023

Videos of the sessions at the October 2023 Patient Carer meeting held in Leeds are now available on the Patient Meetings 2023 section of this site.  

Donations 2023

The Board of Trustees continue to look at how the charity operates in order to keep costs low and bureaucracy to a minimum. Following a review of our financial structure, […]